
Kipuwex
Wireless, continuous care patient monitoring device that measures nine different physiological parameters.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | Growth Equity VC | |
Total Funding | 000k |
EUR | 2018 | 2019 | 2020 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Kipuwex, a Finnish health-tech company, operates in the digital health and Internet of Medical Things (IoMT) sectors. The company was established in 2017 by Marko Höynälä, a serial entrepreneur with over 25 years of experience in telecommunications at companies like Nokia and Broadcom. His background in hardware innovation and a personal passion for accessible healthcare led him to create Kipuwex after winning a local hospital district's innovation competition. The competition sought a solution for objectively measuring pain in children, which became a foundational goal for the company.
The company develops and provides a compact, wireless remote monitoring device that attaches to a patient's chest. This IoMT device is designed to continuously measure up to 12 clinically relevant physiological parameters, which are then accessible to healthcare professionals via a mobile application. Kipuwex's core mission is to provide these health insights affordably, targeting not only established healthcare markets but also developing countries where monitoring devices are often scarce. The business model appears to be centered on selling these devices to healthcare providers, such as hospitals and clinics, and potentially to home users in the future. The company is also exploring veterinary applications for its technology.
A significant feature of the Kipuwex solution is its algorithm that translates physiological data into an objective measurement of pain, addressing a critical need for non-communicative patients like infants or the critically ill. The company has achieved a major regulatory milestone by securing NMPA approval in China, allowing the device to be distributed under the brand name Isogang through a partnership with Bepsun Eurotech Solution Oy. Kipuwex is also actively pursuing market entry into the United States and India, engaging with distributors and health ministries. The company is venture capital-backed, having gone through early-stage VC funding and an accelerator program.
Keywords: remote patient monitoring, medical device, IoMT, vital signs, digital health, health-tech, pain management, telehealth, diagnostics, wearable sensors